Health And Medicine
-
Madhur lands NIH New Innovator Award
Meena Madhur, M.D., Ph.D., assistant professor of Medicine, has received an NIH New Innovator Award, which is designed to support exceptionally creative, early-career investigators who propose innovative, high-impact projects. Read MoreOct 6, 2016
-
Childhood health influences focus of new NIH initiative
The National Institutes of Health (NIH) recently announced it will provide $157 million in awards to launch a multi-center, seven-year initiative that will investigate how exposure to environmental factors in early development — from conception through early childhood — influences the health of children and adolescents. Read MoreSep 29, 2016
-
BMI genotype and breast cancer risk
For breast cancer prevention, a new study provides evidence for lifestyle modification to reduce weight gain in adults. Read MoreSep 29, 2016
-
Targeting norovirus “noxiousness”
New discoveries will guide efforts to develop vaccines or antiviral agents for norovirus, the most common cause of infectious diarrhea. Read MoreSep 28, 2016
-
Center for Research on Men’s Health opens at Vanderbilt
Work has begun at a new universitywide research center with a two-pronged mission to promote men's health and reduce health disparities. Read MoreSep 27, 2016
-
Study shows excess dietary zinc worsens C. diff infection
Too much dietary zinc increases susceptibility to infection by Clostridium difficile — “C. diff” — the most common cause of hospital-acquired infections. Read MoreSep 26, 2016
-
Blood exposures for traditional healers
Traditional healers in sub-Saharan have a high rate of exposure to blood, putting them at risk for HIV and hepatitis C. Read MoreSep 23, 2016
-
H. pylori and anemia – new evidence
The bacterium Helicobacter pylori has been linked to anemia and may be contributing to the incidence and severity of anemia worldwide. Read MoreSep 22, 2016
-
New rules for science researchers would mark an overdue ethics update
New ethical rules for scientists who do experiments involving human beings are about to kick in. It's the first update in more than 40 years. Read MoreSep 16, 2016
-
Study explores anti-viral potential of existing drugs
Emerging viral infections like Zika keep popping up around the world in such quick succession that medicine is having a hard time keeping up. It can take 15 years and more than a billion dollars to bring a new drug to market. Read MoreSep 15, 2016
-
Larger transplant centers produce improved outcomes: study
How many heart transplant programs do we really need? That was a question posed by a group of investigators, including Vanderbilt University Medical Center’s Ashish Shah, M.D., in a novel study that used a computerized algorithm to highlight the value of high-volume transplant centers with corresponding improved outcomes. Read MoreSep 15, 2016
-
Researchers eye potential schizophrenia ‘switch’
Researchers at Vanderbilt University Medical Center have discovered a key mechanism that explains how compounds they’re developing can suppress schizophrenia-like symptoms without side effects in mice. Read MoreSep 15, 2016
-
Study reveals new clues to cystic fibrosis ‘gender gap’
A research team led by structural biologists from Vanderbilt University has come up with the first detailed molecular explanation for a factor that may contribute to the so-called cystic fibrosis (CF) “gender gap.” Read MoreSep 15, 2016
-
Restore T cells to fight leukemia
Modulation of T cell metabolism thus may represent a new therapeutic avenue for leukemia patients. Read MoreSep 14, 2016
-
Risk factors for delirium
High levels of blood markers for vascular endothelial dysfunction were associated with longer periods of confusion in ICU patients, Vanderbilt researchers have discovered. Read MoreSep 13, 2016
-
In search of new cancer targets
Vanderbilt researchers developed a new algorithm to find clinically targetable gene rearrangements in cancers. Read MoreSep 9, 2016
-
Investigators create ‘Trojan Horse’ to fight Ebola
A multi-center research team including scientists from the Vanderbilt Vaccine Center has come up with a clever “Trojan Horse” strategy for thwarting the highly lethal Ebola virus. Read MoreSep 8, 2016
-
Going after the ‘heart attack gremlin’
A protein called Gremlin 2 controls the extent of inflammation after heart attack and may be a good therapeutic target. Read MoreSep 8, 2016
-
Lemonade Stand grant boosts Tansey’s pediatric tumor research
William Tansey, Ph.D., professor of Cell Development and Biology and Ingram Professor of Cancer Research, has been awarded a two-year, $250,000 grant from Alex’s Lemonade Stand Foundation (ALSF) to study malignant rhabdoid tumors (MRTs). Read MoreSep 1, 2016
-
Trial to test whether DBS slows Parkinson’s progression
A consortium led by Vanderbilt University Medical Center (VUMC) researchers has received funding as it makes plans for a multicenter trial that could determine whether deep brain stimulation (DBS) slows the progression of Parkinson’s disease in early-stage patients. Read MoreSep 1, 2016